Molecular Express, Inc.

Molecular Express, a subsidiary of Molecular GPS Technologies™ is a research and development technology company specializing in the application of life science technologies to address market needs across a broad spectrum of industries. The Company's lipid and "Molecular Guided Particle System" (Molecular GPS™) delivery platform is the basis for many active programs targeting anti-cancer therapeutics, drug delivery systems, vaccines, and nanoparticulate drug delivery technologies.

Molecular Express is applying the Molecular GPS™ technology platform to develop vaccines for influenza, herpes, HIV, Anthrax and A. fumigatus. In addition, studies demonstrate that the Molecular GPS™ technology platform can be used to develop a variety of therapeutics to combat cancers and emerging infectious diseases.

Molecular Express exemplifies the Corporate Mission to achieve collaborative excellence with academic entrepreneurs by providing expertise in its core competencies and supporting innovative ideas.